News aggregator
Canopy Growth Corporation Stock (CGC) Surges on Trump Marijuana Rescheduling Reports: Latest News, Forecasts, and What Comes Next (Dec. 15, 2025) - ts2.tech
Categories: News Feeds
Canopy Growth Corporation Stock (CGC) Surges on Trump Marijuana Rescheduling Reports: Latest News, Forecasts, and What Comes Next (Dec. 15, 2025) - ts2.tech
Categories: News Feeds
Cannabis-based drugs show early promise against ovarian cancer, researchers say | Health - Hindustan Times
Cannabis-based drugs show early promise against ovarian cancer, researchers say | Health Hindustan Times
Categories: News Feeds
Cannabis rescheduling may favor Big Pharma - The Guam Daily Post
Cannabis rescheduling may favor Big Pharma The Guam Daily Post
Categories: News Feeds
Cannabis compounds show unexpected power against ovarian cancer - ScienceDaily
Categories: News Feeds
Explainer-How US marijuana reclassification could help cannabis companies - Yahoo! Finance Canada
Explainer-How US marijuana reclassification could help cannabis companies Yahoo! Finance Canada
Categories: News Feeds
SNDL (NasdaqCM:SNDL): Rethinking Valuation After Cannabis Rescheduling Hopes and a Fresh Buyback Signal - Yahoo Finance
SNDL (NasdaqCM:SNDL): Rethinking Valuation After Cannabis Rescheduling Hopes and a Fresh Buyback Signal Yahoo Finance
Categories: News Feeds
Family ordered to pay back over £1 million from cannabis gains - Nation.Cymru
Categories: News Feeds
Is Aurora Cannabis (TSX:ACB) Quietly Repositioning Its Global Strategy Ahead of Possible U.S. Rescheduling? - Yahoo Finance Singapore
Is Aurora Cannabis (TSX:ACB) Quietly Repositioning Its Global Strategy Ahead of Possible U.S. Rescheduling? Yahoo Finance Singapore
Categories: News Feeds
Cannabis-Derived Compounds Show Potential Anti-Cancer Effects Against Ovarian Cancer Cells - geneonline.com
Cannabis-Derived Compounds Show Potential Anti-Cancer Effects Against Ovarian Cancer Cells geneonline.com
Categories: News Feeds
Cannabis Is a Budding Strategy Against Ovarian Cancer - the-scientist.com
Cannabis Is a Budding Strategy Against Ovarian Cancer the-scientist.com
Categories: News Feeds
